HEIDI PETERS: Open Payments
NPI 1447246905 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 45 payments from 20 companies in 2025. Trend: 2023 $1,813 · 2024 $1,083 · 2025 $1,949
Food & beverage: $1,915Education: $34
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $287 |
| AstraZeneca Pharmaceuticals LP | 4 | $255 |
| Pharming Healthcare, Inc. | 3 | $168 |
| Galderma Laboratories, L.P. | 5 | $159 |
| Ionis Pharmaceuticals, Inc. | 2 | $136 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| LEO Pharma Inc. | 2 | $116 |
| Blueprint Medicines Corporation | 1 | $114 |
| Incyte Corporation | 1 | $102 |
| GlaxoSmithKline, LLC. | 3 | $98 |
Products named: DUPIXENT, RUCONEST, NEMLUVIO, AIRSUPRA, AYVAKIT, TEZSPIRE, VOQUEZNA, DAWNZERA.
Industry payments across ID — which companies pay providers there.
